New Technology of PROTACs

by Sunny Fang on Jul 21, 2022 Finance 472 Views

Most of the drugs currently in clinical use are based on small molecules and use the "occupancy-driven" mode of action to inhibit the function of proteins and play a role in the treatment of diseases. Different from traditional small molecule inhibitors and antagonists, protein degradation technology has developed rapidly in recent years because of its ability to induce the degradation of therapeutic target proteins, providing a new idea for the development of new drugs.

PROTACs (Proteolysis-targeting Chimeras), which was first proposed by Crews et al in 2001, can reduce protein levels rather than inhibit protein functions by taking advantage of the natural protein cleaning system in the body. PROTAC is a heterobifunctional molecule with one end connected to a ligand that binds the target protein, one end to an E3 ubiquitin ligase, and a suitable Linker in the middle. PROTAC degradation of target proteins is achieved through the ubiquitin proteasome system (UPS).

Since PROTACs were developed on the basis of POI inhibitors, they still have a certain degree of off-target effects. Second, due to the large molecular weight of PROTAC, its poor cell membrane permeability and poor pharmacokinetic (PK) properties greatly reduce its biological and therapeutic effects. In addition, although some PROTACs can effectively induce the degradation of target proteins, their biological effects are weak and have no effective effect on disease. Finally, most proteins do not have corresponding small molecule conjugates to design PROTACs, such as transcription factors that play an important role in disease development. Since there are few inhibitors of transcription factors, there is no binder available when designing PROTACs targeting transcription factors. This greatly limits the application of PROTAC technology. In order to solve the above problems, different types of PROTAC technologies have emerged in recent years, such as Antibody-PROTAC, Aptamer-PROTAC conjugates, Dual-target PROTACs, Folate-caged PROTACs and TF-PROTACs.

Antibody-PROTAC

Antibody-PROTAC is a new strategy to explore the assembly of new antibody-PROTAC conjugates in combination with antibodies. This technology enables specific degradation of proteins in different cells and tissues, thereby optimizing and maximizing the therapeutic window, reducing the side effects of broad-spectrum PROTACs, and increasing their potential as drugs or chemical tools.

Aptamer-PROTAC conjugates

Aptamers are single-stranded nucleic acids with complex three-dimensional structures, mainly including stems, loops, hairpins and G4 polymers. They bind to target proteins through special effects such as hydrogen bonds, base stacking forces, electrostatic effects, etc., with high specificity and affinity, and can improve the water solubility, membrane permeability, and tumor targeting of traditional PROTACs.

Dual-target PROTACS

In the occurrence and development of cancer, there are usually multiple factors that work together, including different kinds of kinases and growth factors, which can act independently or interfere with each other through signaling networks. This method is mainly to design a single molecule that binds two or more pharmacophore, and simultaneously targets two or more anti-tumor targets.

Folate-caged PROTACs

Folate receptor alpha (FOLR1) is low in normal tissues but highly expressed in many human cancers. Folic acid caged PROTACs is another technology to improve the targeting specificity of PROTACs. The basic principle is to introduce folic acid groups into PROTAC molecules to achieve release in target cells and tissues. In this technique, folic acid releases active PROTAC through the action of endogenous hydrolase in the cell, and then the degradant induces the degradation of the target protein.

TF-PROTACs

Transcription factors (TFs) are a class of proteins involved in gene expression and regulation, and are also potential targets for tumor therapy. Transcription factors, unlike traditional kinases, do not have activity pockets or allosteric regulatory sites commonly found in kinases or other enzymes, making them difficult to target by small molecule inhibitors. Since TFs can bind to specific DNA sequences and regulate the transcription process, it is theoretically possible to target TFs with different DNA sequences instead of small molecule inhibitors. Therefore, TF-PROTAC replaces the small molecule ligand of the targeting protein with the corresponding DNA sequence to form TF-PROTAC, which targets specific TF and induces its degradation, thereby regulating the level and biological function of specific TF.

As a professional PEG derivatives supplier, Biopharma PEG is dedicated to the R&D of PROTAC Linker, providing high purity PEG linkers with various reactive groups to continuously assist your project development. 

Article source: https://article-realm.com/article/Finance/25161-New-Technology-of-PROTACs.html

Reviews

Guest

Overall Rating:

Comments

Comments for unregistered members are disabled

Most Viewed Articles

Latest News

No news items found.

Statistics

Members
Members: 17312
Publishing
Articles: 80,100
Categories: 202
Online
Active Users: 3446
Members: 6
Guests: 3440
Bots: 11942
Visits last 24h (live): 8841
Visits last 24h (bots): 31523

Latest Comments

The faster you ride the more rewards you can collect traffic rider
This news report covers a racial discrimination lawsuit and customer backlash against Walmart after shopper Essie Grundy and viral videos highlighted African-American hair and beauty products...
I appreciate the way this content avoids unnecessary fluff. It’s straightforward and to the point while still offering depth. That economy of words without sacrificing meaning is a true skill...
Finding your account information is even easier shopping at Target! Sign in securely to Target Red Card Login to see your recent transactions, payments, and card activity.   
on Nov 14, 2026 about How To Succeed At Internet Marketing
This article offers practical advice on moving blankets and accessories. Understanding how plastic wraps and moving straps enhance protection is key. For those tricky moves, like downhill with...
This really resonates! I remember struggling with choppy streams and endless buffering with other services. It's frustrating when you just want to relax and watch something. Finding a reliable...
on Nov 13, 2026 about IPTV PAID AND TRIAL SUBSCRIPTIONS
Digital tools such as secure messaging, symptom trackers, and scheduling systems can improve access and engagement.    <a href="https:// snowrider-2.io/">snowrider</a>
This is a really thoughtful breakdown of boundaries, especially in the context of dating. It's something often overlooked but so essential for healthy relationships, even in something as seemingly...
For students and anybody dealing with linear equations, Slope Calculator offers a number of useful advantages. By managing computations automatically, it reduces typical arithmetic errors and...
Its minimalist design is another important reason wordle today maintains a distinctive identity among online games. The interface focuses on the letter grid and the spaces provided for guesses....

Translate To:

Poll

Valet i svergie vilka vinner

Latest Quiz

No active quizzes available yet.